Pharmacy News and Research

RSS

Community pharmacy, also known as retail pharmacy, is the most common type of pharmacy that allows the public access to their medications and advice about their health. Traditionally known as a chemist, it is the healthcare facility that is responsible for the provision of pharmaceutical service to a specific community group or region.

Regeneron and CCPM collaborate to advance human genetics, precision medicine

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system.

11 May 2020

ED clinicians do not show readiness to offer opioid use disorder therapy

A new study by Yale researchers looking at nearly 400 clinicians at four urban academic emergency departments found that, despite scientific evidence supporting the benefits of buprenorphine for opioid use disorder, just 21% of emergency department clinicians indicated readiness to offer it to patients in need.

11 May 2020

Clinical trial launched to evaluate experimental COVID-19 therapies

Clinical leaders from the University of Kentucky's Markey Cancer Center, College of Medicine and College of Pharmacy have launched a clinical trial for experimental therapies to treat patients infected with COVID-19.

11 May 2020

Researchers launch antibody test to understand COVID-19 immunity

University of Kentucky researchers have launched antibody testing that will help to understand what immunity to COVID-19 really means.

11 May 2020

New discovery could end chronic rejection of transplanted organs

Chronic rejection of transplanted organs is the leading cause of transplant failure, and one that the field of organ transplantation has not overcome in almost six decades since the advent of immunosuppressive drugs enabled the field to flourish.

9 May 2020

RNA interference machinery influences epithelial cell biology

Epithelial cells are held together and connected by several different types of structures that form cell-cell contacts.

9 May 2020

Harmful effects of BPA can be reversed by administering coenzyme Q10

Exposure to bisphenol A (BPA), an industrial chemical used to make certain plastics and resins, inner coatings for food cans and bottle tops, thermal paper used in store receipts, dental sealants and so on, is a concern because of possible adverse health effects, including a reduction in fertility.

7 May 2020

Antibiotic Resistance: The Patient Perspective

We discuss the impact of antibiotic-resistant infections on everyday life and the work that is being done to overcome this issue with Antibiotic Research UK.

From Bionow 6 May 2020

New preclinical study shows promise for treating necrotizing enterocolitis

Necrotizing enterocolitis (NEC), a rare inflammatory bowel disease, primarily affects premature infants and is a leading cause of death in the smallest and sickest of these patients.

6 May 2020

Bioactive lipids are key for diagnosis and treatment of cardiac repair after heart attack

Black men and women have higher incidences than whites of developing advanced heart failure following a heart attack.

5 May 2020

Researchers discover a new way to reduce implant rejection

The team from the University of Nottingham's Schools of Pharmacy and Life Sciences have found that the surface shape (topography) and chemical composition of polymer materials can be changed to create materials that control the body's immune response.

4 May 2020

UC San Diego receives $55 NIH grant to advance clinical and translational research

The Altman Clinical and Translational Research Institute at University of California San Diego has received a five-year, $54.7 million Clinical and Translational Science Award from the National Center for Advancing Translational Science, part of the National Institutes of Health.

4 May 2020

Anti-malarial drug use for COVID-19 associated with increased risk of cardiac arrhythmias

Since the World Health Organization declared COVID-19 a Public Health Concern of Global Interest on January 30, more than one million have tested positive for the illness in the United States, and more than 62,000 have died.

3 May 2020

Pharmacy experts urge caution against use of antimalarial drugs to cure COVID-19

PHARMACY experts at the University of Huddersfield are urging caution over claims that widely-available antimalarial drugs could be a "magic bullet" to prevent and cure COVID-19. And the medicines can - if used rashly - have serious side effects.

30 Apr 2020

Researchers test clinical safety of gene-based treatment for achromatopsia

People with complete color blindness are born unable to distinguish colors. They see less sharply and are highly sensitivity to glare.

30 Apr 2020

The Importance of Quality Control on Cannabis Related Products

In this interview, Joshua Crossney talks to News-Medical Life Sciences about the recent advancements in the Cannabis industry and why quality anslyis and quality control are more important now than ever for cannabis medicinal products.

From Pittcon 30 Apr 2020

Study explores the link between burnout and depressive symptoms in medical interns

An article published in the Journal of General Internal Medicine looks at the relationship between burnout and depressive symptoms in medical interns.

30 Apr 2020

Pharmacy-level barriers limit treatment for opioid use disorder in Appalachian Kentucky

A new study led by University of Kentucky researcher April Young and Emory University researcher Hannah Cooper shows that a number of pharmacies in the Appalachian region of Kentucky are limiting the dispensing of buprenorphine, a medication used to treat opioid use disorder.

28 Apr 2020

The approved dose of ivermectin alone not useful in treating COVID-19

A new paper published on the preprint server medRxiv in April 2020 shows that the use of the already approved drug ivermectin in clinical trials to treat severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)s not feasible. This contradicts earlier reports of its ability to suppress the virus in vitro.

27 Apr 2020